Safety and tolerability of colesevelam HCl in patients with T2DM

被引：0
|
作者：
Schwartz, Sherwyn L.
Zieve, Franklin
Kalin, Marcia
Jones, Michael R.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A480 / A480
页数：1
相关论文
共 50 条
  • [1] Colesevelam HCl reduces postprandial glucose in patients with type 2 diabetes mellitus (T2DM)
    Zieve, Franklin
    Schwartz, Sherwyn L.
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A140 - A140
  • [2] Colesevelam HCl improves glycemic control in patients with type 2 diabetes (T2DM): A pilot study
    Schwartz, Sherwyn L.
    Zieve, Franklin
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A134 - A134
  • [3] Colesevelam HCl improves glycaemic control in patients with type 2 diabetes (T2DM): a pilot study
    Jones, M.
    Schwartz, S.
    Zieve, F.
    Kalin, M.
    [J]. DIABETOLOGIA, 2006, 49 : 746 - 747
  • [4] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes (T2DM)
    Kohler, Sven
    Salsali, Afshin
    Hantel, Stefan
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2015, 64 : A302 - A303
  • [5] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [6] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [7] Metformin safety in T2DM patients with psoriasis
    [J]. Reactions Weekly, 2019, 1743 (1) : 10 - 10
  • [8] Statins: liver safety in patients with NASH, T2DM
    [J]. Reactions Weekly, 2017, 1656 (1) : 13 - 13
  • [9] Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)
    Jones, Michael R.
    Ford, Daniel M.
    Baz-Hecht, Merav
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A302 - A302
  • [10] Safety and tolerability of empagliflozin (EMPA) in phase III trials and their extensions in patients with type 2 diabetes (T2DM)
    Roden, M.
    Merker, L.
    Christiansen, A. V.
    Roux, F.
    Hantel, S.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Lund, S. S.
    Hach, T.
    Woerle, H. J.
    Broedl, U. C.
    [J]. DIABETOLOGIA, 2014, 57 : S325 - S326
12345